These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 3480820)
1. Surfactant sufficiency for immature infants--prenatal induction vs. postnatal treatment. Taeusch HW; Smith BT Eur J Respir Dis Suppl; 1987; 153():249-54. PubMed ID: 3480820 [TBL] [Abstract][Full Text] [Related]
2. [The status of prenatal lung ripening]. Wolff F; Bolte A Geburtshilfe Frauenheilkd; 1990 Mar; 50(3):171-6. PubMed ID: 2187733 [TBL] [Abstract][Full Text] [Related]
3. Combined effects of antenatal corticosteroids and surfactant supplementation on the outcome of very low birth weight infants. Modanlou HD; Beharry K; Padilla G; Iriye B J Perinatol; 1996; 16(6):422-8; quiz 429-30. PubMed ID: 8979178 [TBL] [Abstract][Full Text] [Related]
4. Combined hormonal therapy for the prevention of respiratory distress syndrome and its consequences. Moya FR; Gross I Semin Perinatol; 1993 Aug; 17(4):267-74. PubMed ID: 8140441 [TBL] [Abstract][Full Text] [Related]
5. [Intrauterine stimulation for fetal respiratory system maturation; benefits and risks]. Kinalski M; Sledziewski A; Kretowski A Wiad Lek; 2000; 53(9-10):538-45. PubMed ID: 11148922 [TBL] [Abstract][Full Text] [Related]
6. Prevention of respiratory distress syndrome: synergistic therapies. Gross I Mead Johnson Symp Perinat Dev Med; 1988; (33):37-41. PubMed ID: 2485442 [TBL] [Abstract][Full Text] [Related]
7. Requirements of perinatal prevention and treatment of respiratory distress syndrome. Di Renzo GC; Anceschi MM; Guidetti R; Cosmi EV Eur Respir J Suppl; 1989 Mar; 3():68s-72s. PubMed ID: 2662998 [TBL] [Abstract][Full Text] [Related]
8. Lung maturational agents and surfactant treatments: are they complementary in preterm infants? Jobe AH J Perinatol; 1989 Mar; 9(1):14-8. PubMed ID: 2709148 [TBL] [Abstract][Full Text] [Related]
9. Factors affecting responses of infants with respiratory distress syndrome to exogenous surfactant therapy. Ho NK Singapore Med J; 1993 Feb; 34(1):74-7. PubMed ID: 8266136 [TBL] [Abstract][Full Text] [Related]
10. Prenatal dexamethasone and exogenous surfactant therapy: surface activity and surfactant components in airway specimens. Kari MA; Akino T; Hallman M Pediatr Res; 1995 Nov; 38(5):676-84. PubMed ID: 8552433 [TBL] [Abstract][Full Text] [Related]
11. Respiratory morbidity in late-preterm infants: prevention is better than cure! Jain L Am J Perinatol; 2008 Feb; 25(2):75-8. PubMed ID: 18214813 [No Abstract] [Full Text] [Related]
12. [Prenatal prevention of infant respiratory distress syndrome. 2nd part: clinical applications and indications]. Lenclen R; Paupe A; Philippe HJ; Olivier-Martin M; Nisand I J Gynecol Obstet Biol Reprod (Paris); 1995; 24(3):294-309. PubMed ID: 7622778 [TBL] [Abstract][Full Text] [Related]
13. Effects of hormones on fetal lung development. Bizzarro MJ; Gross I Obstet Gynecol Clin North Am; 2004 Dec; 31(4):949-61, xii. PubMed ID: 15550344 [TBL] [Abstract][Full Text] [Related]
15. The biochemistry of fetal lung development. Kresch MJ; Gross I Clin Perinatol; 1987 Sep; 14(3):481-507. PubMed ID: 3311536 [TBL] [Abstract][Full Text] [Related]
16. Surfactant-replacement therapy for respiratory distress in the preterm and term neonate. Engle WA; Pediatrics; 2008 Feb; 121(2):419-32. PubMed ID: 18245434 [TBL] [Abstract][Full Text] [Related]